Insider Transactions in Q1 2021 at Accelerate Diagnostics, Inc (AXDX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2021
|
Matthew Strobeck Director |
BUY
Grant, award, or other acquisition
|
Indirect |
19,531
+10.43%
|
$136,717
$7.68 P/Share
|
|
Feb 19
2021
|
Mark C Miller Director |
BUY
Grant, award, or other acquisition
|
Indirect |
13,020
+50.0%
|
$91,140
$7.68 P/Share
|
|
Feb 19
2021
|
Thomas D Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,680
+22.93%
|
$60,760
$7.68 P/Share
|
|
Feb 19
2021
|
Jack Phillips Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,340
+22.62%
|
$30,380
$7.68 P/Share
|
|
Feb 19
2021
|
John Patience Director |
BUY
Grant, award, or other acquisition
|
Indirect |
21,701
+0.5%
|
$151,907
$7.68 P/Share
|
|
Feb 02
2021
|
Jack W Schuler Director |
BUY
Other acquisition or disposition
|
Indirect |
54,132
+4.11%
|
$487,188
$9.87 P/Share
|
|
Feb 02
2021
|
Jack Phillips Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,313
-23.97%
|
$33,130
$10.9 P/Share
|
|
Feb 01
2021
|
Jack W Schuler Director |
BUY
Other acquisition or disposition
|
Indirect |
100,000
+7.65%
|
$1,100,000
$11.4 P/Share
|
|
Feb 01
2021
|
Jack Phillips Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+41.98%
|
-
|
|
Jan 29
2021
|
Jack W Schuler Director |
BUY
Open market or private purchase
|
Indirect |
30,868
+2.71%
|
$308,680
$10.18 P/Share
|
|
Jan 27
2021
|
Steven Reichling Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-65.27%
|
$375,000
$15.25 P/Share
|
|
Jan 27
2021
|
Steven Reichling Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+39.49%
|
$50,000
$2.98 P/Share
|
|
Jan 26
2021
|
Steven Reichling Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
24,910
-65.19%
|
$298,920
$12.5 P/Share
|
|
Jan 26
2021
|
Steven Reichling Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,910
+39.46%
|
$49,820
$2.98 P/Share
|
|
Jan 25
2021
|
Steven Reichling Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,761
-60.95%
|
$207,610
$10.55 P/Share
|
|
Jan 25
2021
|
Steven Reichling Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,761
+37.87%
|
$41,522
$2.98 P/Share
|